Teva Respiratory Release: ProAir® HFA (Albuterol Sulfate) With Dose Counter Now Available to Patients  
1/3/2013 9:53:31 AM

NORTH WALES, Pa.--(BUSINESS WIRE)--Teva Respiratory announced today the availability of ProAir® HFA with dose counter for use in patients 4 years of age and older, for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm (EIB). The availability of ProAir® HFA with dose counter supports the U.S. Food and Drug Administration’s (FDA) recommendations for such mechanisms, as a means for patients and caregivers to track the number of doses remaining in their inhaler, thus reducing the risk of utilizing an inhaler that no longer contains the medication required at the onset of asthma symptoms.